Projects funded by the NCN
The use of second generation ultrasound contrast agents as an additional element of the diagnosis, monitoring treatment response or therapy side effects observed in children with oncological diseases.
2012/05/B/NZ5/01554
Keywords:
ultrasound contrast enhanced ultrasound CEUS children oncology hematology
Descriptors:
- NZ5_5: Diagnostics in human diseases
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Gdański Uniwersytet Medyczny, Wydział Lekarski
woj. pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 3 - announced on 2012-03-15
Amount awarded: 156 007 PLN
Project start date (Y-m-d): 2013-02-15
Project end date (Y-m-d): 2017-02-14
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled